Case study: breakthrough mpox infection in Aotearoa New Zealand and Australia after completed two-dose course of subcutaneous modified vaccinia Ankara (MVA-BN) vaccines

7 Merad Y, Gaymard A, Cotte L, Perpoint T, Alfaiate D, Godinot M, et al. Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022. Euro Surveill 2022; 27(50): 2200882.
| Crossref | Google Scholar |